CARM1 and cancer: The requirement of CARM1 is implicated in multiple cancers, with its methyltransferase activity particularly addicted by hematopoietic malignancies and metastatic breast cancer (Drew et al., 2017; Greenblatt et al., 2018; Nakayama et al., 2018; Wang et al., 2014a).